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Abstract
Nitrovasodilators, high extracellular Mg2, and some other relaxing agents can cause smooth muscle relaxation without
reductions in myosin regulatory light chain (MRLC) phosphorylation. Relaxations without MRLC dephosphorylation
suggest that other regulatory systems, beyond MRLC phosphorylation, are present in smooth muscle. We tested whether
changes in caldesmon phosphorylation, heat shock protein 20 (HSP20) phosphorylation, or intracellular pH (pHi) could be
responsible for relaxation without MRLC dephosphorylation. In unstimulated tissues, caldesmon was phosphorylated
1.02 þ 0.10 mol Pi/mol caldesmon (mean þ 1 S.E.M.), HSP20 was phosphorylated 0.005 þ 0.003 mol Pi/mol HSP20, and
estimated pHi was 7.21 þ 0.07. Histamine stimulation induced a contraction, an intracellular acidosis, but did not
significantly change caldesmon or HSP20 phosphorylation. Addition of nitroglycerin induced a relaxation, significantly
increased HSP20 phosphorylation to 0.18 þ 0.02 mol Pi/mol HSP20, did not significantly change caldesmon phosphorylation,
and pHi returned to near unstimulated values. Increase in extracellular Mg2 to 10 mM induced a relaxation, but did not
significantly change HSP20 or caldesmon phosphorylation. These data suggest that changes in caldesmon phosphorylation,
HSP20 phosphorylation, or pHi cannot be the sole explanation for relaxation without MRLC dephosphorylation. However,
it is possible that HSP20 phosphorylation may be involved in nitroglycerin-induced relaxation without MRLC
dephosphorylation. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Most excitatory stimuli induce smooth muscle con-
traction by increasing myoplasmic Ca2 concentra-
tion, formation of the 4Ca2-calmodulin-myosin
light chain kinase (MLCK) complex, and phosphor-
ylation of Ser19 in the myosin regulatory light chains
(MRLC) [1]. In most cases, smooth muscle relaxa-
tion is felt to be the reversal of this process: reduc-
tion in Ca2, inhibition of MLCK, and MRLC de-
phosphorylation [2].
There are several agents that cause greater relaxa-
tion than predicted by reductions in MRLC phos-
phorylation. Typically, these relaxing agents decrease
force to near resting values, while MRLC phosphor-
ylation only decreases modestly to a value still sig-
ni¢cantly greater than resting values. Such relaxa-
tions include the responses to activators of guanylyl
cyclase, such as NO or inhibitors of phosphodiester-
0925-4439 / 00 / $ ^ see front matter ß 2000 Elsevier Science B.V. All rights reserved.
PII: S 0 9 2 5 - 4 4 3 9 ( 9 9 ) 0 0 1 1 2 - X
* Corresponding author. Box 146, Cardiovascular Division,
University of Virginia Health System, Charlottesville, VA
22908, USA. Fax: +1-804-924-9604;
E-mail : crembold@virginia.edu
BBADIS 61912 16-2-00
Biochimica et Biophysica Acta 1500 (2000) 257^264
www.elsevier.com/locate/bba
ases that elevate cellular [cGMP] [3^6]. Other situa-
tions are treatment with okadaic acid, a non-speci¢c
phosphatase inhibitor [7], some Ca2 depletion pro-
tocols [8,9], some Ca2 channel blockers [10], high
extracellular Mg2 [11], and other combinations of
excitatory and inhibitory stimuli [12]. This phenom-
enon has been studied mostly in vascular smooth
muscle; however, it is most dramatic in tissues,
such as the corpus cavernosum, where inhibitory in-
nervation is a key physiological control mechanism
[6].
One potential reason for relaxation without
MRLC dephosphorylation is that the MRLC could
be phosphorylated on a di¡erent amino acid residue.
However, we found that MRLC phosphorylation
during relaxation with nitroglycerin [3] and or high
extracellular magnesium [11] induced relaxation was
all on Ser19, suggesting that MRLC phosphorylation
at inactive sites cannot explain uncoupling of force
from MRLC phosphorylation.
Relaxations without MRLC dephosphorylation
suggest that MRLC phosphorylation is not the
only determinant of activation and cross-bridge cy-
cling in smooth muscle, but do not establish the im-
portance or the physiological role of a Ca2-inde-
pendent regulatory mechanism.
There are other candidate regulatory systems for
force in smooth muscle (reviewed in [13]): (1) the
thin ¢lament proteins caldesmon and calponin can
alter thin ¢lament function; (2) myosin can both
bind Ca2 (at a low a⁄nity) and be phosphorylated
on the heavy chain; (3) phorbol diesters, presump-
tively by activation of protein kinase C, can induce
contraction by an unknown cascade; (4) some inves-
tigators propose non-crossbridge mediated stress in
the form of cytoskeletal domain crosslinks; (5)
changes in intracellular pH (pHi) have been reported
to alter the relation between Ca2 and contraction
[14,15]; and ¢nally, (6) phosphorylation of heat
shock protein 20 (HSP20) has been found to corre-
late with cyclic nucleotide-induced relaxation [16].
In this study, we evaluated three potential force
regulatory systems to determine whether they could
have a role in relaxation without MRLC dephos-
phorylation. We studied the role of caldesmon phos-
phorylation, HSP20 phosphorylation, and pHi dur-
ing relaxation induced by nitroglycerin or high
extracellular magnesium. We previously showed
that these agents induce relaxation without MRLC
dephosphorylation [3,11].
2. Materials and methods
2.1. Tissues
Swine common carotid arteries were obtained
from a slaughterhouse and transported at 0‡C in
physiological salt solution (PSS). PSS contained
(mM): NaCl, 140; KCl, 4.7; 3-[N-morpholino] pro-
pane sulfonic acid (MOPS) 5; Na2HPO4, 1.2; CaCl2,
1.6; MgSO4, 1.2; D-glucose, 5.6; pH adjusted to 7.4
at 37‡C. Dissection of medial strips, mounting and
determination of the optimum length for stress devel-
opment at 37‡C was performed as described. [17].
The intimal surface was mechanically rubbed to re-
move the endothelium.
2.2. 32P-Labeling of intact tissues
Tissues were prepared and mounted as described
above. Tissues were placed in PO4-free PSS and in-
cubated with 32Pi (32P-orthophosphate) 300 WCi/strip
(0.18 mCi/ml) for 4^5 h at 37‡C. Tissues were rinsed
and stretched for 1 h, subjected to treatments, and
frozen in dry ice/acetone slurry as described [18].
Frozen tissues were split into two pieces: one for
caldesmon extraction and the other for determina-
tion of the radiospeci¢c activity of tissue [Q-32P]ATP.
2.3. Measurement of caldesmon phosphorylation
This procedure was modi¢ed from that described
by Dr. Len Adam [19]. Half of the tissue was ho-
mogenized on ice in 0.4 ml of homogenization bu¡er
containing (in mM) Tris, 25 (pH 8.8); Na-pyrophos-
phate, 100; NaCl, 250; EGTA, 10; EDTA, 5, NaF,
50; NP-40, 0.1%; DTT, 0.01; and PMSF, 0.001.
The homogenates were centrifuged for 2 min at
14 000Ug. The supernatant was boiled for 10 min
and centrifuged again for 2 min at 14 000Ug. The
supernatant was diluted 1:10 in equilibration bu¡er
containing (mM) MOPS, 20 (pH 7.0); EDTA, 1;
EGTA, 1; and DTT, 1. The diluted supernatant
was then applied to a 0.5-ml DEAE-Sephacel column
(Sigma, I-6505). The columns were washed with 1.2
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ml equilibration bu¡er and then 1.2 ml 0.15 M NaCl.
For Fig. 1 the caldesmon was then eluted with in-
creasing concentrations of NaCl as described. Since
the caldesmon eluted with 0.2^0.3 M NaCl, we eluted
caldesmon in all other experiments with 1 ml of 0.3
M NaCl after washing with 0.15 M NaCl. The elu-
tion was run on a 12% SDS PAGE gel, stained with
Coomassie blue and 32P activity determined by cut-
ting out the caldesmon bands and scintillation count-
ing. The amount of protein was determined by com-
parison with caldesmon standards loaded on the gel.
2.4. ATP speci¢c activity determination
The remaining portion of the 32P-labeled tissue
was homogenized in 0.2 ml 10% trichloroacetic acid
at 4‡C, centrifuged and the supernatant washed three
times with ether at 4‡C as described [18]. The sample
was lyophilized and resuspended in 30 Wl water. Ali-
quots were incubated in 100 mM Tris bu¡er pH 8.0
(at 30‡C); 5 mM MgCl2 ; 2 mM dithiothreitol; con-
taining 2 mg/ml phosphorylase b, 0.1 mg/ml phos-
phorylase kinase. Aliquots were taken at 30 min,
spotted on cellulose ¢lter paper and immersed in
cold 10% trichloroacetic acid; 4% disodium pyro-
phosphate. Filters were washed four times with
TCA, each 10 min; washed once each in 95% etha-
nol, ethyl ether, dried and radioactivity measured by
liquid scintillation spectrometry. Sample speci¢c ac-
tivities were determined by comparison with a stan-
dard curve derived from samples of known [32P]ATP
speci¢c activities that were assayed under the same
conditions. Preliminary studies established that the
reaction had proceeded to completion by 30 min.
Stoichiometry of caldesmon phosphorylation (mol
Pi/mol caldesmon) was calculated by multiplying
the dpm/Wg caldesmon by the MW of caldesmon
(Wg/Wmol) and then dividing by the speci¢c activity
of [Q-32P]ATP (dpm/Wmol [Q-32P]ATP) [18].
2.5. Measurement of HSP20 phosphorylation
Swine carotid arteries were pharmacologically
treated and frozen in an acetone dry ice slurry [17].
After air drying, the tissues were homogenized a
bu¡er containing 1% SDS, 10% glycerol, and 20
mM dithiothreitol. Full strength, half strength, and
quarter-strength dilutions of samples were then sep-
arated on one-dimensional isoelectric focusing (pI 5^
8), blotted to nitrocellulose, immunostained with a
rabbit polyclonal anti-HSP20 antibody, and detected
with enhanced chemiluminescence. The dilutions en-
sured that the enhanced chemiluminescence detection
system was in the linear range. We made anti-HSP20
antibody by injecting rabbits with gel puri¢ed re-
combinant HSP20 (sequence con¢rmed by mass
spectroscopy).
2.6. Intracellular pH measurement
Intracellular pH was measured with BCECF
loaded intracellularly by incubation of dissected tis-
sues in the acetomethoxy ester of BCECF (BCECF-
AM, Molecular Probes, Eugene, OR) [20]. The ¢nal
loading solution was MOPS PSS containing 4 WM
BCECF-AM, 0.133 mg/ml Pluronic F127, and
0.66% dimethylsulfoxide. Arterial strips were loaded
at 37‡C for 1 h and washed in PSS for 1^1.5 h before
each experiment. The experimental apparatus con-
sisted of a Nikon xenon light source, the output of
which was directed through a rotating ¢lter wheel
that had 436 þ 13 nm and 485 þ 12 nm ¢lters rotating
at 3000 rpm. Excitation light passed through one
arm of a bifurcated light guide, which was placed
0.5^1 mm from the luminal surface of the smooth
muscle tissue. The tissue was isometrically mounted
to a Harvard Bioscience capacitive force transducer
and bathed in a 3-ml jacketed tissue bath. The sec-
ond arm of the bifurcated light guide passed emission
light through a 530 þ 15 nm ¢lter to a photomulti-
plier tube. Fluorescence signals were electronically
demultiplexed and the force, 436 and 485 £uores-
cence signals were converted to digital signals and
stored on a personal computer.
2.7. Calibration of BCECF signals
After completing pharmacological manipulations,
tissues were incubated in a calibration solution con-
taining 3 WM nigericin, KCl, 145; MOPS, 5; CaCl2,
1.6; MgSO4, 1.2; D-glucose, 5.6; EDTA, 0.02; pH
adjusted to 6.8 or 7.4 at 37‡C (this solution has no
added Na) and a two point calibration performed
at 7.4 and 6.8 as described [20]. We found that the
relationship between pHo and the 485/436 ratio was
linear between pH 6.6 and 7.8 (n = 5). Calculated pHi
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estimates are approximate because: (1) some photo-
bleaching and dye leakage occurred during the ex-
periment; (2) nigericin may not totally equilibrate
the pH gradient in all cells; and (3) protein binding
can alter the £uorescent properties of BCECF[21].
We were interested in the e¡ects of changes in pHi ;
therefore, signals are reported as change in pHi
rather than absolute pHi. This normalization de-
creased variability caused exclusively by di¡erences
in estimates of basal pHi.
2.8. Statistics
Phosphorylation, BCECF signals, and force were
compared with an ANOVA with Newman^Keuls
tests for individual comparisons. Signi¢cance was de-
¢ned as P6 0.05.
3. Results
Caldesmon is a thin ¢lament protein. Caldesmon
has both actin and myosin binding domains and ap-
pears to weakly tether myosin and actin [22]. Despite
this tethering action, binding of caldesmon to actin
decreases binding of myosin to actin and decreases
myosin’s actin activated ATPase activity [22,23]. Cal-
desmon can be phosphorylated up to 2 mol Pi/mol
caldesmon. Dephosphorylated caldesmon is a more
potent inhibitor of myosin’s actin activated ATPase
than phosphorylated caldesmon [24] although this
e¡ect appears dependent on solution composition
[22]. There are three reports detailing caldesmon
phosphorylation in smooth muscle; all are in swine
carotid artery. High [K]o [25], phorbol dibutyrate
[25], endothelin [19], and angiotensin II [19] all in-
creased caldesmon phosphorylation (measured 60
min after stimulation). With high [K]o stimulation,
the time course of changes in caldesmon phosphory-
lation was slower than the time course of contraction
and relaxation [25]. Sustained angiotensin II stimu-
lation was associated with a sustained increase in
caldesmon phosphorylation despite the decrease in
force associated with tachyphylaxis [19]. Another
group found no change in caldesmon phosphory-
lation with high [K]o, histamine, or norepinephrine
stimulation [26]. These studies suggest that caldes-
mon phosphorylation does not simply correlate
with contraction, i.e. (1) caldesmon phosphorylation
changed slower than force during high [K]o con-
traction/relaxation cycles; and (2) caldesmon phos-
phorylation remained elevated despite tachyphylaxis
with angiotensin II.
We measured caldesmon phosphorylation in
32PO4-loaded swine carotid arterial tissues [27].
Brie£y, tissues were homogenized, boiled, and pro-
Fig. 1. Demonstration of caldesmon puri¢cation. SDS electrophoresis gels of fractions collected from the DEAE Sephacel columns
loaded with homogenates from unstimulated swine carotid artery. (A) A Coomassie blue stained gel showing puri¢ed gizzard caldes-
mon (labeled ‘s’), fractions 1^6 corresponding to elution from the column with 0.1, 0.15, 0.2, 0.25, 0.3, and 0.35 M NaCl, and molec-
ular weight standards. (c) An autoradiogram of fractions 1^5 (0.1^0.3 M NaCl). (C) A Western blot with anti-caldesmon antibody.
The arrows show that caldesmon (CaD) eluted in fractions 3^5 corresponding to 0.2^0.3 M NaCl.
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teins present in the supernatant separated by DEAE
chromatography and then 1D SDS electrophoresis
(protocol from Len Adam, see Section 2). The boil-
ing is a crucial step as it eliminates the majority of
cellular proteins that are not heat stable. Fig. 1
shows a SDS gel stained with Coomassie blue, an
autoradiogram of a second gel, and a Western blot
of a third gel. Caldesmon eluted from the DEAE
Sephacel column in the 0.2^0.3 M NaCl fractions
(lanes 3^5). Detection by anti-caldesmon antibodies
(Fig. 1C) identify these bands as caldesmon. The
autoradiogram (Fig. 1B) demonstrates that caldes-
mon was labeled with 32PO4. Fig. 1A shows that
gizzard caldesmon migrated at a similar, but not
identical MW, as swine caldesmon. This extraction
system was used to measure caldesmon phosphory-
lation in intact swine carotid.
Caldesmon was phosphorylated 1.02 þ 0.10 mol Pi/
mol (mean+1 S.E.M., n = 9) in unstimulated tissues.
Histamine (3 WM) stimulation induced a contraction
but did not signi¢cantly change caldesmon phos-
phorylation. Addition of 10 WM nitroglycerin to his-
tamine stimulated tissues induced a signi¢cant relax-
ation, but did not signi¢cantly change caldesmon
phosphorylation. In histamine-stimulated tissues, in-
crease in extracellular Mg2 to 10 mM by addition of
MgCl2 induced a signi¢cant relaxation, but did not
signi¢cantly change caldesmon phosphorylation.
These data suggest that alterations in caldesmon
phosphorylation cannot be responsible for nitrogly-
cerin- or high extracellular Mg2-induced relaxation
without MRLC dephosphorylation (Fig. 2).
Heat shock protein 20 (HSP20) may have a role in
cyclic nucleotide-induced smooth muscle relaxation.
The laboratory of Colleen Brophy found that cyclic
nucleotide-dependent relaxation was associated with
phosphorylation of HSP20 in bovine carotid smooth
muscle [16]. HSP20 is highly homologous to the
small heat shock proteins KB crystallin and HSP27
[28]. HSP25 (the rat form of HSP27) was ¢rst char-
acterized as an inhibitor of actin polymerization [29].
Phosphorylation of HSP27 by p38 MAP kinase in-
creases the stability of actin ¢laments in cells exposed
to cytochalasin D [30]. Antibodies to HSP27 inhib-
ited bombesin-induced contraction of rabbit anal
smooth muscle [31]. These data suggest that
HSP27, a close relative of HSP20, may be able to
Fig. 2. Lack of a correlation between caldesmon phosphory-
lation and either contraction or relaxation. Nine sets of swine
carotid artery tissues were loaded with 32Pi and then either: (1)
not stimulated; (2) stimulated with 3 WM histamine alone for
30 min; (3) stimulated with 3 WM histamine for 10 min and
then relaxed by addition of 10 WM nitroglycerin for 20 min (la-
beled H+NTG); or (4) stimulated with 3 WM histamine for 10
min and then relaxed by addition of 10 mM Mg2 for 20 min
(labeled H+Mg). Contractile force was then measured and the
tissues frozen for caldesmon phosphorylation measurement. The
bar graph shows that caldesmon phosphorylation was not sig-
ni¢cantly changed (by Newman^Keuls test) despite signi¢cant
changes in force. Force was normalized to that observed with
3 WM histamine.
Fig. 3. A representative Western blot of HSP20 immunoreactiv-
ity. A tissue (stimulated with 10 WM histamine for 10 min and
then relaxed by addition of 10 WM nitroglycerin for 20 min)
was homogenized, proteins separated by isoelectric focusing, im-
munostained with rabbit anti-HSP20 antibody, and imaged
with enhanced chemiluminescence. The upper band is unphos-
phorylated HSP20 and the lower (more acidic) band is
phosphorylated HSP20. The left lane is full-strength homoge-
nate, the center is half-strength, and the right is quarter-
strength homogenate.
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regulate contractile proteins. Interestingly, HSP20
contains a cGMP/cAMP-dependent protein kinase
consensus phosphorylation site, while HSP27 does
not [28]. There are at least two HSP20 isoforms:
an acidic form that predominates in swine carotid
and a basic form that predominates in urogenital
smooth muscle (data not shown). We therefore mea-
sured HSP20 phosphorylation in swine carotid artery
relaxed with protocols that caused relaxation without
MRLC dephosphorylation.
A representative Western blot of HSP20 immuno-
reactivity from a tissue stimulated with 10 WM hista-
mine for 10 min and then relaxed by addition of 10
WM nitroglycerin for 20 min is shown in Fig. 3. The
upper bands are the unphosphorylated acidic isoform
of HSP20 and the lower (more acidic) band are
phosphorylated acidic isoform of HSP20. The lanes
left to right show serial dilutions of homogenate
demonstrating that the enhanced chemiluminescence
detection system was in its linear range.
HSP20 was phosphorylated 0.005 þ 0.003 mol Pi/
mol (mean+1 S.E.M., n = 6) in unstimulated tissues.
Histamine (10 WM) stimulation induced a contrac-
tion but did not signi¢cantly change HSP20 phos-
phorylation (Fig. 4). Addition of 10 WM nitroglycerin
to histamine stimulated tissues induced a signi¢cant
relaxation and a signi¢cant increase in HSP20 phos-
phorylation to 0.18 þ 0.02 mol Pi/mol HSP20. In his-
tamine-stimulated tissues, increase in extracellular
Mg2 to 10 mM by addition of MgCl2 induced a
signi¢cant relaxation, but did not signi¢cantly
change HSP20 phosphorylation. These data suggest
that increases in HSP20 phosphorylation could have
a role in nitroglycerin-induced relaxation without
MRLC dephosphorylation. However, alterations in
HSP20 phosphorylation cannot be responsible for
high extracellular Mg2-induced relaxation without
MRLC dephosphorylation.
Changes in pH a¡ect many enzymatic processes,
and the signal transduction pathway in smooth
muscle is no exception. Depolarization and contrac-
tile agonist stimulation induced various degrees of
intracellular acidosis in several types of intact
smooth muscle tissue [20,32,33]. In isolated smooth
Fig. 4. Correlation between HSP20 phosphorylation with nitro-
glycerin, but not magnesium-induced relaxation. Six sets of
swine carotid artery tissues were: (1) not stimulated; (2) stimu-
lated with 10 WM histamine alone for 30 min; (3) stimulated
with 10 WM histamine for 10 min and then relaxed by addition
of 10 WM nitroglycerin for 20 min (labeled H+NTG); or (4)
stimulated with 3 WM histamine for 10 min and then relaxed by
increasing extracellular Mg2 to 10 mM for 20 min (labeled
H+Mg). Contractile force was then measured and the tissues
frozen for HSP20 phosphorylation measurement. The bar graph
shows that HSP20 phosphorylation was signi¢cantly increased
by treatment with nitroglycerin (by Newman^Keuls test). Both
nitroglycerin and magnesium-induced signi¢cant relaxations.
Force was normalized to that observed previously with 109
mM extracellular K.
Fig. 5. pHi during nitroglycerin-induced relaxation. The e¡ect
of nitroglycerin on histamine-induced changes in BCECF esti-
mated pHi (top panel) and contractile stress (bottom panel) in
swine carotid media tissues. The tissues were stimulated with 10
WM histamine at 0 min and 100 WM nitroglycerin was added at
10 min (the mean is shown in a solid line with þ 1 S.E.M. in
dotted lines, n = 4) For comparison, the e¡ect of 10 WM hista-
mine alone at 0 min followed by washing out histamine at 10
min is shown in open squares as mean þ 1 S.E.M.
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muscle cells, changes in pHi can alter [Ca2]i or Ca2
in£ux/e¥ux [34^37]. In skinned smooth muscle, large
decreases in pHi (from 6.9 to 6.5 or 6.2) increased the
[Ca2]i sensitivity of force. [14,15] These investigators
used BAPTA (a Ca2 chelator that is less sensitive to
changes in pH than EGTA) to clamp [Ca2]i at spe-
ci¢c levels. Therefore, their results are less susceptible
to artifacts from change in pH on the EGTA bu¡er
system. Acidosis also slowed the rate of force devel-
opment by slowing changes in myosin phosphory-
lation.[15]
We measured pHi in swine carotid medial tissues
that were loaded with the pH-sensitive dye BCECF.
Basal estimated pHi was 7.21 þ 0.07 (n = 4) in those
tissues bathed in a physiologic saline containing the
organic pH bu¡er MOPS. Fig. 5 shows the e¡ect of
histamine stimulation and nitroglycerin-induced re-
laxation on pHi and contraction in swine carotid
artery. Histamine (10 WM) stimulation induced a rap-
id contraction and a gradual decrease in pHi. Addi-
tion of 100 WM nitroglycerin induced a rapid and
prolonged relaxation (solid line as a running mean
with dotted lines as þ 1 S.E.M.). Nitroglycerin in-
duced a much slower increase in pHi to near resting
values. It should be noted that the BCECF signal 1^2
min after addition of histamine (when force was
high) was similar to the BCECF signal 20 min after
addition of nitroglycerin (when force was low). Fig. 4
also shows that washout of histamine after 10 min of
contraction was also associated with a rapid relaxa-
tion and a slow increase in pHi to near resting val-
ues, a response similar to that observed with nitro-
glycerin-induced relaxation. We previously found
that washout of histamine was associated with reduc-
tions in Ca2 to resting values [2]. These data suggest
that relaxation was associated with an increase in
pHi that was similar, regardless of the mechanism
inducing relaxation, i.e. whether the relaxation was
caused by decreases in [Ca2] induced by washing
out histamine or processes beyond MRLC phosphor-
ylation induced by nitroglycerin. There was no large
change in pHi that could account for relaxation with-
out MRLC dephosphorylation.
4. Discussion
These data show that HSP20 phosphorylation was
increased by addition of nitroglycerin to histamine
stimulated swine carotid artery. It is therefore possi-
ble that HSP20 phosphorylation may be involved in
nitroglycerin-induced relaxation without MRLC de-
phosphorylation. However, relaxations induced by
high extracellular magnesium, which is known to in-
duce relaxation without MRLC dephosphorylation
[11], were not associated with HSP20 phosphory-
lation. This result suggests that HSP20 phosphory-
lation is not responsible for all forms of relaxation
without MRLC dephosphorylation.
The data also suggest that neither changes in cal-
desmon phosphorylation nor pHi can explain relax-
ation without MRLC dephosphorylation in swine
carotid artery. However, these data do not rule out
a role for focal change in pHi or other mechanisms
that regulate caldesmon function. Further research is
needed to determine: (1) whether HSP20 phosphor-
ylation is responsible for nitroglycerin-induced relax-
ation; and (2) the mechanism responsible for magne-
sium-induced relaxation.
Finally, these data also show that histamine stim-
ulation did not signi¢cantly alter caldesmon phos-
phorylation levels above that observed in unstimulat-
ed tissues. This result supports one prior report [26]
that changes in caldesmon phosphorylation do not
appear to correlate with contraction. Phosphory-
lation of caldesmon does not appear to be important
in regulation of contraction in swine carotid artery.
However, these data do not rule out a role for cal-
desmon in contraction if it is regulated by other
mechanisms.
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